Vildagliptin and metformin are two medications that are often used together in the treatment of type 2 diabetes. Vildagliptin is a medication that belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors, while metformin is a medication that belongs to a class of drugs called biguanides.
Vildagliptin works by inhibiting the enzyme DPP-4, which helps to increase the levels of incretin hormones in the body. These hormones stimulate the release of insulin from the pancreas and reduce the amount of glucose produced by the liver.
Metformin works by reducing the amount of glucose produced by the liver and by improving the sensitivity of the body's cells to insulin. This helps to lower blood sugar levels in people with type 2 diabetes.
When used together, vildagliptin and metformin can help to improve blood sugar control in people with type 2 diabetes. They are typically taken orally, in the form of a tablet, and the dosage and duration of treatment may vary depending on the patient's medical condition and response to the medication.
Common side effects of vildagliptin and metformin may include nausea, diarrhea, vomiting, and abdominal discomfort. It is important to talk to a healthcare professional about the potential benefits and risks of these medications before taking them, especially if you have a history of kidney problems or liver disease. Regular monitoring of kidney function and blood sugar levels is often necessary during treatment with vildagliptin and metformin.